AAAAAA

   
Results: 1-7 |
Results: 7
IMMUNIZATION WITH TCR V-BETA PEPTIDE ELIMINATES THE TYPE-II COLLAGEN ANTIGEN-SPECIFIC CELLULAR IMMUNE-RESPONSE IN MICE PROTECTED FROM COLLAGEN-INDUCED ARTHRITIS (CIA)
Authors: ANTHONY DD HEEGER PS HAGGI TM
Citation: Dd. Anthony et al., IMMUNIZATION WITH TCR V-BETA PEPTIDE ELIMINATES THE TYPE-II COLLAGEN ANTIGEN-SPECIFIC CELLULAR IMMUNE-RESPONSE IN MICE PROTECTED FROM COLLAGEN-INDUCED ARTHRITIS (CIA), Arthritis and rheumatism, 41(9), 1998, pp. 405-405
EFFECTIVE TUMOR VACCINES GENERATED BY IN-VITRO MODIFICATION OF TUMOR-CELLS WITH CYTOKINES AND BISPECIFIC MONOCLONAL-ANTIBODIES
Authors: GUO YJ CHE XY SHEN F XIE TP MA J WANG XN WU SG ANTHONY DD WU MC
Citation: Yj. Guo et al., EFFECTIVE TUMOR VACCINES GENERATED BY IN-VITRO MODIFICATION OF TUMOR-CELLS WITH CYTOKINES AND BISPECIFIC MONOCLONAL-ANTIBODIES, Nature medicine, 3(4), 1997, pp. 451-455
EFFECTIVE CELLULAR VACCINES GENERATED BY IN-VITRO OR IN-VIVO MODIFICATION OF TUMOR-CELLS USING GENE AND NON-GENE TRANSFER APPROACHES FOR CANCER-IMMUNOTHERAPY
Authors: GUO YJ SHEN F XIE TP CHE XY WANG XN WU SG SHI LH ZONG M LIU GL ANTHONY DD WU MC
Citation: Yj. Guo et al., EFFECTIVE CELLULAR VACCINES GENERATED BY IN-VITRO OR IN-VIVO MODIFICATION OF TUMOR-CELLS USING GENE AND NON-GENE TRANSFER APPROACHES FOR CANCER-IMMUNOTHERAPY, Cancer gene therapy, 4(5), 1997, pp. 314-315
TREATMENT OF HEPATOCELLULAR-CARCINOMA BY THE COMBINATION OF ACTIVE AND ADOPTIVE IMMUNOGENE THERAPY - A PHASE I II CLINICAL-TRIAL/
Authors: XIE T SHEN F SHI L TROJAN J ANTHONY DD WU MC GUO YJ
Citation: T. Xie et al., TREATMENT OF HEPATOCELLULAR-CARCINOMA BY THE COMBINATION OF ACTIVE AND ADOPTIVE IMMUNOGENE THERAPY - A PHASE I II CLINICAL-TRIAL/, Cancer gene therapy, 4(5), 1997, pp. 335-336
TREATMENT OF HEPATOCELLULAR-CARCINOMA BY IN-VIVO COTRANSFECTION OF ANTISENSE IGF-1 AND B7 GENES COMBINED WITH ADOPTIVE IMMUNOGENE THERAPY -A PHASE I II CLINICAL-TRIAL/
Authors: GUO YJ SHEN F CHE XY XIE TP WANG XN WU SG SHI LH ZONG M ANTHONY DD WU MC
Citation: Yj. Guo et al., TREATMENT OF HEPATOCELLULAR-CARCINOMA BY IN-VIVO COTRANSFECTION OF ANTISENSE IGF-1 AND B7 GENES COMBINED WITH ADOPTIVE IMMUNOGENE THERAPY -A PHASE I II CLINICAL-TRIAL/, Cancer gene therapy, 4(1), 1997, pp. 67-67
GENE-THERAPY OF RAT-BRAIN GLIOBLASTOMA BY AN EPISOME-BASED TRANSCRIPTIONAL CASSETTE EXPRESSING ANTISENSE IGF-I CDNA
Authors: JOHNSON TR TROJAN J ANTHONY DD RUDIN SD TYKOCINSKI ML ILAN J ILAN J
Citation: Tr. Johnson et al., GENE-THERAPY OF RAT-BRAIN GLIOBLASTOMA BY AN EPISOME-BASED TRANSCRIPTIONAL CASSETTE EXPRESSING ANTISENSE IGF-I CDNA, Indian Journal of Biochemistry & Biophysics, 31(1), 1994, pp. 1-13
GENE-THERAPY OF MURINE TERATOCARCINOMA - SEPARATE FUNCTIONS FOR INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II IN IMMUNOGENICITY AND DIFFERENTIATION
Authors: TROJAN J JOHNSON TR RUDIN SD BLOSSEY BK KELLEY KL SHEVELEV A ABDULKARIM FW ANTHONY DD TYKOCINSKI ML ILAN J ILAN JP
Citation: J. Trojan et al., GENE-THERAPY OF MURINE TERATOCARCINOMA - SEPARATE FUNCTIONS FOR INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II IN IMMUNOGENICITY AND DIFFERENTIATION, Proceedings of the National Academy of Sciences of the United Statesof America, 91(13), 1994, pp. 6088-6092
Risultati: 1-7 |